European Innovation Council

ProFuse Technology Awarded €2.4 Million EIC Grant to Accelerate Cultivated Meat Production

Retrieved on: 
Wednesday, May 8, 2024

This prestigious grant recognizes ProFuse's innovative technology and its potential to revolutionize the cultivated meat industry.

Key Points: 
  • This prestigious grant recognizes ProFuse's innovative technology and its potential to revolutionize the cultivated meat industry.
  • Selected from a Competitive Pool: ProFuse was chosen for the EIC grant after a rigorous selection process involving hundreds of applicants.
  • This recognition serves as a strong validation of ProFuse's technology and its value proposition within the cultivated meat landscape.
  • This grant will allow us to further refine our technology to support large-scale cultivated meat production."

Stream Analyze Enters the U.S. to Make "Stupid" Machines Smart with Edge AI Solution

Retrieved on: 
Thursday, April 25, 2024

UPPSALA, Sweden, April 25, 2024 /PRNewswire-PRWeb/ -- Stream Analyze, the software platform for edge analytics that enables AI models to be developed, deployed, and evolved on any device, announces its expansion into the United States. Partnering with Microchip and other U.S. companies, Stream Analyze democratizes AI access across any sector. Stream Analyze's platform transforms previously "stupid" machines into intelligent IoT assets, allowing customers to unlock the full potential of AI and monetize data directly on the edge.

Key Points: 
  • Partnering with Microchip and other U.S. companies, Stream Analyze democratizes AI access across any sector.
  • Stream Analyze's platform transforms previously "stupid" machines into intelligent IoT assets, allowing customers to unlock the full potential of AI and monetize data directly on the edge.
  • "Expanding into the U.S. market is a milestone for Stream Analyze, as it opens doors to a hotbed of innovation and technology," said Jan Nilsson, co-founder and CEO of Stream Analyze.
  • This level of insight and agility in AI deployment is something only Stream Analyze can deliver."

Powerful Medical's AI Breakthrough Marks a New Dawn in Heart Attack Diagnostics with EIC Support Doubles Sensitivity in Identifying Acute Coronary Occlusion on 12-Lead ECG

Retrieved on: 
Monday, March 18, 2024

With a landmark advancement in medical diagnostics, Powerful Medical has distinguished itself within the competitive digital health landscape.

Key Points: 
  • With a landmark advancement in medical diagnostics, Powerful Medical has distinguished itself within the competitive digital health landscape.
  • At the core of its mission, Powerful Medical introduces the PMcardio platform, a CE-certified medical device leveraging proprietary AI to analyze electrocardiograms (ECGs) with remarkable precision.
  • This platform is capable of diagnosing heart attacks — specifically, occlusion myocardial infarctions — significantly earlier and with double the sensitivity compared to the current standard of care.
  • - Robert Herman, MD, Chief Medical Officer
    As Powerful Medical begins its Series A fundraising, the EIC Accelerator's grant and investment endorse the company's vision and technology.

Europe Leaps Ahead in Global AI Arms Race, Joining $20 Million Investment in NeuReality to Advance Affordable, Carbon-Neutral AI Data Centers

Retrieved on: 
Tuesday, March 19, 2024

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240319442956/en/
    NeuReality co-founders (left to right) Yossi Kasus, Moshe Tanach, Tzvika Shmueli (Photo: Business Wire)
    This $20 million raise brings NeuReality’s total funding to $70 million.
  • NeuReality’s efficient AI-centric system architecture enables companies to run generative AI applications and large language models (LLMs) without overinvesting in scarce and underutilized GPUs.
  • By connecting directly to Ethernet, NR1 efficiently manages AI queries from vast data pipelines originating from millions of users and billions of devices.
  • The additional $20 million propels NeuReality for broader AI Inference deployment as both conventional and generative AI applications surge in demand.

Pilot Photonics secures large european funding win to develop key technologies for CPO scaling

Retrieved on: 
Monday, March 25, 2024

The explosion in data processing due to the adoption of AI/ML is putting further pressure on datacentre networks and in large computing arenas.

Key Points: 
  • The explosion in data processing due to the adoption of AI/ML is putting further pressure on datacentre networks and in large computing arenas.
  • New architectures are emerging to tackle this problem but already scaling challenges are appearing and new innovations will be needed to overcome them.
  • Supported by this EIC funding Pilot Photonics will mature a number of its patented technologies including comb lasers, ring resonator IQ modulators and comb-enhanced DSP algorithms.
  • These innovations are relevant to both pluggable and CPO architectures today and can help unlock coherent communication inside the datacentre.

Pilot Photonics secures large european funding win to develop key technologies for CPO scaling

Retrieved on: 
Monday, March 25, 2024

The explosion in data processing due to the adoption of AI/ML is putting further pressure on datacentre networks and in large computing arenas.

Key Points: 
  • The explosion in data processing due to the adoption of AI/ML is putting further pressure on datacentre networks and in large computing arenas.
  • New architectures are emerging to tackle this problem but already scaling challenges are appearing and new innovations will be needed to overcome them.
  • Supported by this EIC funding Pilot Photonics will mature a number of its patented technologies including comb lasers, ring resonator IQ modulators and comb-enhanced DSP algorithms.
  • These innovations are relevant to both pluggable and CPO architectures today and can help unlock coherent communication inside the datacentre.

Powerful Medical Secures €7.5M in Funding from European Innovation Council to Revolutionize Heart Attack Diagnostics with AI

Retrieved on: 
Friday, March 1, 2024

AALST, Belgium, March 01, 2024 (GLOBE NEWSWIRE) -- Powerful Medical leads the battle against cardiovascular diseases, the number one cause of death worldwide, with heart attacks accounting for the majority of these fatalities. The company's flagship AI-powered ECG interpretation platform, PMcardio, is setting a new standard in cardiac diagnostics, enabling healthcare professionals to detect acute heart attacks, also known as occlusion myocardial infarction, along with 38 other cardiac abnormalities at the first point of contact. The certified medical device analyzes any image of a 12-lead ECG and compares it against millions of previous patient records, enabling early and precise diagnosis—a critical gap in current healthcare practices.

Key Points: 
  • Powerful Medical, a pioneering medical device manufacturer, proudly announces being selected to receive a €2.5 million grant and a follow-on €5 million investment from the European Innovation Council (EIC) .
  • Chosen from over one thousand applicants , Powerful Medical stands out as a driver of innovation focused on transforming the field of cardiovascular diagnostics.
  • Backed by the European Innovation Council, Powerful Medical is escalating its clinical validation efforts and expanding its footprint throughout Europe.
  • Their commitment to innovation and improving patient care establishes Powerful Medical as a key player in transforming heart care with AI on a worldwide scale.

Dxcover Announces Three New Clinical Trials for Brain, Colorectal and Lung Cancer Detection

Retrieved on: 
Tuesday, January 9, 2024

Dxcover Limited , a clinical-stage diagnostics company pioneering multi-omic spectral analysis (MOSA) for early detection of multiple cancers, today announced it is initiating three pivotal clinical trials measuring efficacy of the company’s liquid biopsy technology for the detection of brain, colorectal and lung cancer.

Key Points: 
  • Dxcover Limited , a clinical-stage diagnostics company pioneering multi-omic spectral analysis (MOSA) for early detection of multiple cancers, today announced it is initiating three pivotal clinical trials measuring efficacy of the company’s liquid biopsy technology for the detection of brain, colorectal and lung cancer.
  • The company has launched its EMBRACE study, a 2,200-patient trial focused on the early detection of brain cancer.
  • Dxcover® Brain Cancer is a qualitative in vitro diagnostic (IVD) test analyzing blood serum by infrared spectroscopy to detect the signals indicative of brain cancer.
  • The Dxcover Brain Cancer test has been developed over four years with clinical support from NHS Lothian.

DTE Concludes a Total Investment Round of $16M in 2023

Retrieved on: 
Friday, December 22, 2023

“We're thrilled to successfully close a meaningful series A2 round of $16M this year, in a challenging funding environment,” stated Karl Matthiasson, CEO and Cofounder of DTE.

Key Points: 
  • “We're thrilled to successfully close a meaningful series A2 round of $16M this year, in a challenging funding environment,” stated Karl Matthiasson, CEO and Cofounder of DTE.
  • This breakthrough capability provides enhanced process control and decision support, empowering manufacturers and metals producers with unprecedented real-time information.
  • Kristinn Pálmason, Managing Director at Eyrir Vöxtur, commented: “We’re extremely enthusiastic about our investment in DTE.
  • We see immense potential in DTE’s innovative approach, which not only enhances operational efficiencies but also drives sustainability in a crucial industry.”

DTE’s Groundbreaking Technology Featured in "Innovation and Disruption Leaders" Docuseries

Retrieved on: 
Thursday, December 14, 2023

REYKJAVIK, Iceland, Dec. 14, 2023 (GLOBE NEWSWIRE) -- DTE, a leading innovator in process and quality control for the metals production and manufacturing industry, offers a glimpse into its innovative technology and its applications in a new documentary series, "Innovation and Disruption Leaders." The series showcases leading businesses and individuals who are reshaping industries and pushing the boundaries of what is possible.

Key Points: 
  • REYKJAVIK, Iceland, Dec. 14, 2023 (GLOBE NEWSWIRE) -- DTE , a leading innovator in process and quality control for the metals production and manufacturing industry, offers a glimpse into its innovative technology and its applications in a new documentary series, "Innovation and Disruption Leaders."
  • The series showcases leading businesses and individuals who are reshaping industries and pushing the boundaries of what is possible.
  • At the heart of DTE's breakthrough innovation is its real-time elemental analysis technology , an industry-first advancement that promises to revolutionize the whole metals industry.
  • This technology enables real-time process control, an unprecedented advancement that promises to minimize waste and optimize production efficiency in the energy-intensive metals industry.